Our inability to detect PHD3 promoter DNA methylation in primary human prostate tumors was surprising, however our results are supported by a recent study by Huang et al. [38], who screened 168 invasive breast carcinomas and did not find evidence of PHD3 DNA methylation using melting curve analysis of bisulfite converted DNA. The gene discussed is EGLN3; the disease is invasive breast carcinoma.